Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hair Color
|
312 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Skin Pigmentation
|
72 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||
INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC (disorder)
|
2 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.700 | 0 | |||||||
OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF
|
3 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.700 | 0 | |||||||
SKIN/HAIR/EYE PIGMENTATION 2, RED HAIR/FAIR SKIN
|
3 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.700 | 0 | |||||||
melanoma
|
515 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.090 | 0.889 | 9 | 2001 | 2019 | ||||
Parkinson Disease
|
990 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.040 | 0.750 | 4 | 2015 | 2016 | ||||
Cutaneous Melanoma
|
248 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.030 | 1.000 | 3 | 2000 | 2019 | ||||
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)
|
13 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.020 | 1.000 | 2 | 2005 | 2008 | ||||
Familial glucocorticoid deficiency
|
4 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Hereditary Melanoma
|
67 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||
Malignant neoplasm of skin
|
38 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||
Multiple Sclerosis
|
1022 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
REM Sleep Behavior Disorder
|
16 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.010 | 1 | 2016 | 2016 | |||||
Vitiligo
|
249 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
92 | 0.732 | 0.240 | 16 | 89919736 | missense variant | C/T | snv | 4.7E-02 | 4.8E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 |